Job posting: chemistry teacher, Regis High School, New York City, NY

Via C&EN Jobs: 

Position Summary

Regis seeks a qualified candidate to join its faculty as a Chemistry Teacher beginning September 2024 for the Academic Year 2024-2025. This is a full-time faculty position. Position comes with full benefits. Work hours may vary and will include some evenings and weekends for special school events. Salary is very competitive for the New York City area and is commensurate with experience. The 2024-2025 school year for faculty members ends on June 13, 2025.

Job Responsibilities

• Supports and Advances the Catholic Jesuit Mission of the School
• Works in collaboration with the administration in observing the principles and ideals for which Regis High School stands for
• Devotes energies to teaching in conformity with the policies of Regis High School and is subject at all times to the general control and supervision of the Principal
• Will perform services that include the preparation of examinations, the correction and assignment of grades, and assigned proctoring
• Responsible for ongoing professional development, the customary conferences with students and parents, individual guidance of students, serving as an academic advisor with a student advisement group, direction of student extracurricular activities, service on faculty committees, active service in studying department and school issues, preparation of syllabi, attendance at events listed in the school’s Faculty Handbook under “Faculty Staff Participation in Key Events,” attendance at faculty meetings, and participation in other such professional incidental services, in the judgment of the Principal, the needs of the school require
• Will be generally available to the students in their assigned department resource room through the school day when not teaching class; further, is to have one hour after school availability weekly, according to a schedule subject to the approval of the Principal

Qualifications & Skills

• Position includes teaching 10th grade chemistry classes
• Position may include working with students in advanced individual science projects in school’s SRP Program (Science Research Program) and may include teaching an advanced chemistry class in the future
• Experience working with adolescents
• Excellent organization and communication skills
• Successful teaching experience (high school or higher education)
• Familiarity with and understanding of practical uses of technology for instruction

Education

• B.S. Degree with a major in Biology or Chemistry is required
• Master's Degree in Biology or Chemistry or a Master of Science in Education is preferred
• Evidence of continuing professional education through conferences, seminars, or professional associations is preferred

Compensation & Benefits

Salary range - $71,660. Commensurate with years of experience and level of success in the institutional advancement area, eligible for most benefits immediately.

Most benefits go into effect immediately. Participation in the 403 (b) occurs after one year of employment.

To Apply:

Interested applicants should submit a cover letter and resume by email to employment@regis.org. Qualified applicants will be contacted regarding next steps once all required documents have been submitted. Applications will be accepted until the position is filled.

Full ad here. Best wishes to those interested. 

The craziest hybrid sheep story you will hear today

Via Twitter and the Department of Justice: 

Defendant Worked to Traffic Marco Polo Sheep Parts from Kyrgyzstan, Clone Sheep, Illegally Inseminate Ewes to Create Hybrids and Traffic Rocky Mountain Bighorn Sheep Parts

A Montana man pleaded guilty today to two felony wildlife crimes – a conspiracy to violate the Lacey Act and substantively violating the Lacey Act – as part of an almost decade-long effort to create giant sheep hybrids in the United States with an aim to sell the species to captive hunting facilities.

Arthur “Jack” Schubarth, 80, of Vaughn, Montana, is the owner and operator of Sun River Enterprises LLC – also known as Schubarth Ranch – which is a 215-acre alternative livestock ranch in Vaughn. The Schubarth Ranch is engaged in the purchase, sale and breeding of “alternative livestock” such as mountain sheep, mountain goats and various ungulates. The primary market for Schubarth’s livestock is captive hunting operations, also known as shooting preserves or game ranches.

According to court documents, Schubarth conspired with at least five other individuals between 2013 and 2021 to create a larger hybrid species of sheep that would garner higher prices from shooting preserves. Schubarth brought parts of the largest sheep in the world, Marco Polo argali sheep (Ovis ammon polii), from Kyrgyzstan into the United States without declaring the importation. Average males can weigh more than 300 pounds with horns that span more than five feet. Marco Polo argali are native to the high elevations of the Pamir region of Central Asia. They are protected internationally by the Convention on International Trade in Endangered Species, domestically by the U.S. Endangered Species Act and are prohibited in the State of Montana to protect native sheep from disease and hybridization.

Schubarth sent genetic material from the argali parts to a lab to create cloned embryos. Schubarth then implanted the embryos in ewes on his ranch, resulting in a single, pure genetic male Marco Polo argali that he named “Montana Mountain King” or MMK.

Court documents explain that Schubarth worked with the other unnamed coconspirators to use MMK’s semen to artificially impregnate various other species of ewes – all of which were prohibited in Montana – and create hybrid animals. Their goal was to create a larger and more valuable species of sheep to sell to captive hunting facilities, primarily in Texas.

Presuming this is true, I can't feel very sorry for Mr. Schubarth. I do wonder if the people who were doing the cloning knew what he was doing, and if they knew it was illicit.  

WuXi in the NYT

There's an article in the New York Times about the BIOSECURE Act, and its impact with WuXi on the general pharmaceutical market. This is the only relevant portion (I feel): 

Last month, after a classified briefing with intelligence staff, the Senate homeland security committee advanced a bill by a vote of 11 to 1: It would bar companies from receiving government contracts for work with Wuxi, but would allow the companies to still obtain contracts for unrelated projects. Government contracts with drugmakers are generally limited, though they were worth billions of dollars in revenue to companies that responded to the Covid-19 pandemic.

The real question is 1) will a bill pass, and 2) what will the bill look like? If the Senate version looks like this (i.e. banning the government from working directly with WuXi, but not stopping pharma companies from working with WuXi), I suspect this is going to not be particularly impactful.

The 2024 Chemistry Faculty Jobs List: 548 research/teaching positions and 84 teaching positions

The 2024 Chemistry Faculty Jobs List (curated by Andrew Spaeth and myself) has 548 research/teaching positions and 82 teaching positions. 

Want to help out? Here's a Google Form to enter positions.

To see trending, go to Andrew Spaeth's visualization of previous years' list.

On April 18, 2023, the 2023 Chemistry Faculty Jobs List had 619 research/teaching positions and 80 teaching-focused positions.

Want to talk anonymously? Have an update on the status of a job search? Here's the first open thread. Here's a link to the second, open thread. Here's a link to the current, third open thread. 

Don't forget to click on "load more" below the comment box for the full thread.  

What's wrong with the new MLB uniforms?

That's a sweaty uniform. 
Credit: The Athletic

Also in this week's C&EN, this vitally important topic (article by Prachi Patel): 

Soon after the 2024 Major League Baseball (MLB) season started in March, sweat stains began to bloom along with spring flowers. In particular, sweat seemed to be soaking through the gray uniform jersey that team members wear when they play away from home, turning them visibly dark.

It shouldn’t surprise anyone, especially sports apparel companies, that athletes sweat. And synthetic sport performance fabrics, whether they’re intended for soccer, track, tennis, or lower-impact activities, are designed to provide temperature control and antibacterial properties to help keep their wearers comfortable and fresh.

In fact, 6 years’ worth of engineering went into the Nike Vapor Premier baseball uniforms, designed by Nike and manufactured by Easton, Pennsylvania–based Fanatics, according to the MLB. So what went wrong?

C&EN asked textile researchers to speculate, and they had fun doing it. “Textile structures are incredibly complex, and when you add chemical finishes, the degree of complexity multiplies,” says Juan Hinestroza, professor of fiber science and apparel design at Cornell University. So the answer to what possibly went wrong is “all of the above,” he says...

Because I'm a chemical manufacturing weirdo, this from the article makes the most sense to me. 

...Whatever the underlying chemical or material gaffe, the problem most likely stems from the uniforms’ complex manufacturing chain. Every MLB jersey and pair of pants is the product of multiple fiber and yarn producers, textile mills, and chemical suppliers spread across the world. To Henry Boyter, an expert on textiles and finishes and director of the Center for Environmentally Sustainable Textile and Apparel Businesses, it’s probably a quality control issue. “There is a large amount of testing that should have been done to ensure quality and that was probably not done,” he says. “We only know for sure that human wear trials were not completed, or ignored.”

I am rather surprised that these issues didn't turn up in their testing, or they ignored these issues. Either way, it doesn't seem like this is turning out well for MLB. I suspect that the second version of these uniforms will be better, but we shall see. 

Bloomberg: Metals prices are surging

Via Bloomberg: 

Aluminum and nickel surged on the London Metal Exchange as traders responded to new US and UK sanctions that banned deliveries of any Russian supplies produced after midnight on Friday.

The new restrictions, aimed at curbing President Vladimir Putin’s ability to fund his military, inject major uncertainties into metals markets that have already been reshaped in the aftermath of Russia’s invasion of Ukraine.

Aluminum jumped as much as 9.4%, the most since the current form of the contract was launched in 1987, while nickel rose as much as 8.8%. That suggests traders believe that removing one of the largest producers from the market will drive prices higher.

The rally is being fueled by “worries that the sanctions will reduce Russian flows to Western markets,” said Jia Zheng, head of trading and research at Shanghai Dongwu Jiuying Investment Management Co. “Any stimulation will be amplified amid an existing bullish backdrop.”

Still, there are also concerns over the prospect of a flood of old Russian metal — which is still permitted — getting dumped onto the LME.

I'm still learning the metals supply chains, so I don't think I have much to say about this, but it is still fascinating. 

Have a great weekend

I have one big thing to do today, and then I get to have a weekend. Here's hoping that you got your work done, and that you're having a great week. Have a good weekend and we'll see you on Monday. 

Moderna pauses its Kenyan manufacturing site

Via FiercePharma: 

Moderna made headlines in 2021 with a commitment to bringing more mRNA manufacturing capabilities to Africa, eventually landing on Kenya as the site of a $500 million plant project. Now, amid waning global vaccine demand, the company has hit pause on the endeavor.

The Spikevax maker is taking a step back to evaluate future demand for mRNA vaccines in Africa as it has not received any vaccine orders from the continent since 2022, Moderna said in a statement.

Cancelations of previous orders have stacked up to “more than $1 billion” in losses and write-downs, according to the mRNA specialist. The company said demand "has declined since the pandemic and is insufficient to support the viability of the factory planned in Kenya." 

Too bad - I was looking forward to the start of biopharma manufacturing in Africa. Here's hoping for brighter days. 

Job posting: CMC reviewer, FDA, Silver Spring, MD

Via the Chemistry Discord (deadline is April 12):

The mission of the Center for Drug Evaluation and Research (CDER) is to perform an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. CDER regulates over-the-counter (OTC) and prescription drugs, including biological therapeutics and generic drugs.

The Office of Pharmaceutical Quality (OPQ) oversees and coordinates the overall regulation of pharmaceutical quality within CDER, including quality assessment of regulatory submission, manufacturing facility assessment, research, policy development, and surveillance of the quality of marketed pharmaceutical products.

The Offices of Product Quality Assessment (OPQA) III evaluate and assess product quality aspects over the product lifecycle for all types of human drug product applications, including Investigational New Drugs (INDs), Biologics Licensing Applications (BLAs), New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), and Active Pharmaceutical Ingredients (API) information supporting these applications, and make risk-informed recommendations on the approvability of such products and evaluates and assesses post-marketing activities for these drug products.

Duties/Responsibilities

As the Pharmaceutical Scientist, the incumbent is responsible for reviewing and evaluating comprehensive information and data on chemistry, formulation, manufacturing (including process monitoring and controls), biopharmaceutics (including drug release), as well as technical aspects of labeling and environmental impact submitted in Biologic License Agreements (BLAs), New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), and supplemental BLAs, NDAs, as appropriate. 

Full ad here. Best wishes to those interested. 

Drones as corporate intelligence tools

Via the New York Times, this interesting news about a plastics recycling plant: 

Then in November, Bleecker Street Research — a New York-based short-seller, an investment strategy that involves betting that a company’s stock price will fall — published a report asserting that the white pellets that had rolled off PureCycle’s line in June weren’t recycled from plastic waste. The short-sellers instead claimed that the company had simply run virgin polypropylene through the system as part of a demonstration run.

Mr. Olson said PureCycle hadn’t used consumer waste in the June 2023 run, but it hadn’t used virgin plastic, either. Instead it had used scrap known as “post industrial,” which is what’s left over from the manufacturing process and would otherwise go to a landfill, he said.

Bleecker Street also said it had flown heat-sensing drones over the facility and said it found few signs of commercial-scale activity. The firm also raised questions about the solvent PureCycle was using to break down the plastic, calling it “a nightmare concoction” that was difficult to manage.

PureCycle is now being sued by other investors who accuse the company of making false statements and misleading investors about its setbacks.

Mr. Olson declined to describe the solvent. Regulatory filings reviewed by The New York Times indicate that it is butane, a highly flammable gas, stored under pressure. The company’s filing described the risks of explosion, citing a “worst case scenario” that could cause second-degree burns a half-mile away, and said that to mitigate the risk the plant was equipped with sprinklers, gas detectors and alarms.

It is fascinating to see how these short selling firms work, and it's pretty clever to fly drones to find out more data (beats counting cars in a parking lot, I bet.)  

The 2024 Chemistry Faculty Jobs List: 547 research/teaching positions and 82 teaching positions

The 2024 Chemistry Faculty Jobs List (curated by Andrew Spaeth and myself) has 547 research/teaching positions and 82 teaching positions. 

Want to help out? Here's a Google Form to enter positions.

To see trending, go to Andrew Spaeth's visualization of previous years' list.

On April 11, 2023, the 2023 Chemistry Faculty Jobs List had 618 research/teaching positions and 77 teaching-focused positions.

Want to talk anonymously? Have an update on the status of a job search? Here's the first open thread. Here's a link to the second, open thread. Here's a link to the current, third open thread. 

Don't forget to click on "load more" below the comment box for the full thread.  

Job posting: visiting assistant professor, Point Loma Nazarene University, San Diego, CA

Via Twitter: 

PLNU is a Christian liberal arts university in the evangelical, Wesleyan tradition, offering quality undergraduate, graduate and professional programs. We provide higher education in a vibrant Christian environment where minds are engaged and challenged, character is modeled and formed, and service is an expression of faith. PLNU is an institution that is committed to reflecting the rich diversity of God’s kingdom. We therefore encourage applications from culturally and academically diverse faculty of the highest caliber, skilled and/or demonstrating great potential in the practice of teaching and scholarship. 

The Department of Chemistry is seeking candidates for a one year Visiting Professor of Chemistry. Responsibilities will begin mid-August 2024 and continue until mid-May, 2025. Academic rank will be based on degrees and experience, and the compensation level also depends upon the education and experience of the appointee. Review of applications will begin immediately and continue until the position is filled. The University encourages applications from a diverse group of applicants who support the mission of Point Loma Nazarene University.

Full ad here. Best wishes to those interested. 

C&EN: "Chemours completes financial probe"

In this week's C&EN, this news (article by Alexander H. Tullo):  

Chemours’s board of directors has completed an internal review of accounting irregularities that led to the ouster of CEO Mark Newman. In February, Newman was placed on leave pending the review. The probe found that $100 million in payments from Chemours to vendors due in the fourth quarter of 2023 were delayed until the first quarter of this year. Meanwhile, Chemours’s collection of $260 million in receivables due in the first quarter of this year was pushed to the fourth quarter of 2023. The moves boosted the company’s cash flow numbers. The audit found similar gaming in 2022 of $40 million in payments delayed and $175 million in receivables accelerated. Newman has resigned, but the audit may not close the book on the scandal. More than half a dozen law firms are preparing shareholder suits against the company. 

It is remarkable to me that Mr. Newman would decide to attempt this sort of accounting finagling, especially with a publicly traded company. 

Have a great weekend

Well, this has been a pretty chill week (by comparison) for me. Here's hoping that you've had a great week, and that you have a wonderful weekend. See you on Monday! 

Chemical drums found buried beneath a New York community park

Credit: Patch/Town of Oyster Bay

Via Patch: 

BETHPAGE, NY — Six 55-gallon chemical drums were found buried seven feet beneath Bethpage Community Park near the ball field and skatepark, the Town of Oyster Bay announced Wednesday. Supervisor Joseph Saladino renewed demands for Northrop Grumman to excavate all contaminated soils in the park.

"These chemical drums are encased in concrete coffins, which is highly uncommon according to environmental experts," the Town of Oyster Bay wrote.

The town called it a "graveyard of chemical drums."

A Grumman spokesperson said the company discovered several drums encased in concrete beneath a closed area of the park while conducting environmental remediation.

"We promptly notified NYSDEC and other relevant stakeholders and we are working with NYSDEC to assess and address this situation as quickly as possible," Grumman stated. "We remain committed to protecting the health and well-being of the community and to continuing our partnership with NYSDEC and other government regulators to address environmental conditions in the area."

It is really hard to imagine a world in which hazardous waste was not disposed of "properly."* It would be fascinating to know what the thought process around burying these drums were, and what potential other disposal methods there might have been years ago. 

*I'm loathe to credit federal legislation for business regulation, but it seems to me that a United States with RCRA is better than one without. 

Job posting: Associate Principal Investigator, Toxinology, Battelle National Biodefense Institute, Frederick, MD

Via C&EN Jobs: 

BACKGROUND

The National Biodefense Analysis and Countermeasures Center (NBACC) is a one-of-a-kind facility dedicated to defending the nation against biological threats. Its work supports DHS and National biodefense preparedness planning, response, emerging threat characterization and bioforensic analyses. It is the first national laboratory created by DHS in response to biodefense gaps identified following the Amerithrax attacks of 2001 and has been operated by the Battelle National Biodefense Institute (BNBI) since 2006. Since its inception, NBACC and its staff have filled critical shortfalls in our scientific knowledge of biological agents needed to protect the public and defend the Nation from biological threats, whether naturally occurring, accidental, or deliberate and provided federal law enforcement with scientific data to support the investigation and attribution of biocrimes and protection of the US bioeconomy.

NBACC includes two centers: the National Bioforensic Analysis Center (NBFAC), which conducts the technical analyses in support of federal law enforcement investigations, and the National Biological Threat Characterization Center (NBTCC), which conducts experiments and studies to obtain data required for a better understanding of biological vulnerabilities and hazards. Together these centers offer a unique national resource for understanding the risks posed by biological agents and emerging technologies to inform biodefense policy and response planning and the operational capability to support the investigation, prosecution, and prevention of biocrimes and bioterrorism.

PRIMARY FUNCTION

Applies expertise in protein and peptide biochemistry in collaboration with a team of scientists in the NBTCC within the NBACC to perform Toxinology research that addresses specific questions of national significance in support of biodefense preparedness, response, and recovery. Areas of research include a range of topics related to the physical, biological, and/or pathological properties of toxin agents. Work will be performed in state-of-the-art laboratories. All facilities are fully staffed and equipped with a wide range of technologies required for biodefense and infectious disease research.

MINIMUM REQUIRED QUALIFICATIONS

• Requires a PhD (or equivalent) in a scientific discipline or engineering, and a minimum of 2 years related experience.
• Requires expertise in one or more of the following:
• Heterologous protein expression, purification, and characterization.
• Solid phase peptide and protein synthesis, purification, and characterization.
• Cell-based toxicity and/or electrophysiological assays.

Full ad here. Best wishes to those interested. 

Tennessee General Assembly passes bill to ban atmospheric geoengineering

Via the BBC, this news:

Tennessee lawmakers have passed a bill banning the release of airborne chemicals that critics say is inspired by "chemtrails" conspiracy theories.

The bill forbids "intentional injection, release, or dispersion" of chemicals into the air.

It doesn't explicitly mention chemtrails, which conspiracy theorists believe are poisons spread by planes.

Instead it broadly prohibits "affecting temperature, weather, or the intensity of the sunlight".

The Republican-sponsored bill passed along party lines on Monday. If it is signed by Tennessee's governor, Republican Bill Lee, it will go into effect on 1 July.

Just to check, I verified that this was an actual bill that was actually debated and voted on (and passed) in the Tennessee General Assembly. This was not an April Fool's Joke.** Sadly, an amendment to add Sasquatch was voted down (I think.)

I wonder if Tennessee state representative Monty Fritts is concerned about other chemicals in the atmosphere? Surely he understands that, say, burning anything puts chemicals into the atmosphere that could affect temperature and weather?

*Here's another article from a different outlet showing the bill's movement through the general assembly.  

NSF: 1% fewer postdocs in academia in 2022

Via Science's Katie Langin, this news from NSF's Survey of Graduate Students and Postdoctorates in Science and Engineering: 

New data released by the U.S. National Science Foundation (NSF) reveal a sharp drop in the number of U.S. citizens working as postdocs, especially in the biological and biomedical sciences. The trend underscores concerns that the academic community is facing a postdoc shortage and that early-career scientists are increasingly favoring higher paid positions outside academia.

“It’s an unfortunate situation if domestic researchers are turning down postdoctoral positions because they’re inferior to positions in government or in industry,” says Tom Kimbis, executive director and CEO of the National Postdoctoral Association. “It’s not a situation that’s good for the country.”

The data come from NSF’s Survey of Graduate Students and Postdoctorates in Science and Engineering, which compiles employment data from academic institutions and estimates the number of STEM graduate students and postdocs across the country. According to the latest data release, 62,750 postdocs were employed at U.S. institutions in the fall of 2022, a 1% drop compared with the year before. But the trend diverges sharply by citizenship. From 2021 to 2022, the number of U.S. citizens and permanent residents working as postdocs dropped from 29,755 to 27,289. The 8% change is the largest year-to-year percentage-wise drop in the history of the survey, which has collected data since 1980. Meanwhile, the number of postdocs with temporary visas increased by 6%, from 33,573 to 35,461, about the same number as in 2020.

This is pretty interesting news. I'm genuinely interested to see if this trend continues, if it indeed is a trend. I'm generally skeptical of narratives that there is a "shortage" of postdocs. I think there is a perceived shortage of candidates from professors, or (another way to put it) the relative desirability of these postdocs has fallen. I have long asserted that postdocs are inferior goods, and this doesn't change my position.  

The 2024 Chemistry Faculty Jobs List: 546 research/teaching positions and 82 teaching positions

The 2024 Chemistry Faculty Jobs List (curated by Andrew Spaeth and myself) has 546 research/teaching positions and 82 teaching positions. 

Want to help out? Here's a Google Form to enter positions.

To see trending, go to Andrew Spaeth's visualization of previous years' list.

On April 4, 2023, the 2023 Chemistry Faculty Jobs List had 618 research/teaching positions and 75 teaching-focused positions.

Want to talk anonymously? Have an update on the status of a job search? Here's the first open thread. Here's a link to the second, open thread. Here's a link to the current, third open thread. 

Don't forget to click on "load more" below the comment box for the full thread.  

An alarming story about WuXi, and its (potential) impact on chemical employment in the United States

Via Derek, this seriously bonkers Reuters story regarding WuXi AppTec: 

March 28 (Reuters) - U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec (603259.SS), opens new tab had transferred U.S. intellectual property to Beijing without consent, according to two sources.

The U.S. government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by China's military, and the proposed legislation would restrict U.S. government funds going to those Chinese companies.

The classified briefing to about a dozen senators was led by the FBI, the State Department and the Office of the Director of National Intelligence. Those officials said that WuXi AppTec and other Chinese entities had engaged in activity in the U.S. contrary to U.S. national security interests, the sources said on condition of anonymity.

Among the agencies' concerns was information reflected in recent intelligence reporting that WuXi AppTec transferred a U.S. client's intellectual property to Chinese authorities without consent, the two sources said.

First, I am a little skeptical of this story. I'm probably more of a dot mil type than Derek, to calibrate. I am, in general, pretty skeptical of specific stories about foreign governments without additional corroboration. So, the rest of this post will needs to start with "IF this is true" and I think it's a big "IF." 

IF this is true, then I suspect this is sufficient evidence for Congress to move on whatever legislation they are planning. The fact that the intelligence community is providing these briefings to Congress intimates a potential level of agreement and potential assent from the White House, which presumably will attempt to adjust any future bills via the Senate. 

So. IF this is all true, then you could imagine A Great Decoupling away from China IF indeed there is large-scale evidence that WuXi is either voluntarily or involuntarily coughing up American IP to the Chinese government.* I remember a story (I don't know if I entirely believe it) from a friend, or a friend of a friend who was taken to a rooftop on the WuXi campus in the late aughts and told "that's the Merck building over there, and the Pfizer building over there, and the [insert large pharma] building over there." Again, I'm skeptical of these stories, but suffice it to say in 2024 that there are many thousands more FTEs in China working on pharma (med chem, process, etc) than there were in 1990 or 2000. 

IF there is a Great Decoupling, then yes, some (or many?) of these jobs will eventually end back up in the United States. Likelier, though, they will start somewhere else. India, perhaps, or maybe Central/Eastern Europe. I don't see the numbers of chemists increasing in the US dramatically any time soon, but my crystal ball is murky. That said, IF a WuXi bill is signed, and IF there are serious consequences (i.e. if large pharmas are barred from working with WuXi on pain of, say, being removed from the CMS formulary), then all bets are off. IF. 

*The Chinese government is weird in all sorts of ways - but why would they have a meal on seed corn like this?